[Integral treatment of congenital Chagas disease: the Bolivian experience ].

Simple item page
dc.contributor.authorEduardo Suárez
dc.contributor.authorCristina Alonso‐Vega
dc.contributor.authorFaustino Torrico
dc.contributor.authorMarisol Córdova
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:05:58Z
dc.date.available2026-03-22T15:05:58Z
dc.date.issued2005
dc.descriptionCitaciones: 7
dc.description.abstractWe have analyzed the response to the treatment with benznidazol in newborns and nurslings in the Hospital Materno Infantil Germán Urquidi of Cochabamba, Bolivia, between 1999 and 2002. It is important an integral treatment of the nursling with a subsequent information directed to the family. The response was close to 100% when the treatment was correctly administrated. They were not adverse effects and the detected biochemical alterations did not present clinical significance.
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/16482807
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/50373
dc.language.isoen
dc.publisherNational Institutes of Health
dc.relation.ispartofPubMed
dc.sourceUniversity of San Simón
dc.subjectAdverse effect
dc.subjectChagas disease
dc.subjectMedicine
dc.subjectPediatrics
dc.subjectDisease
dc.subjectGerman
dc.subjectInternal medicine
dc.title[Integral treatment of congenital Chagas disease: the Bolivian experience ].
dc.typearticle

Files

Collections

Artículo Científico Publicado